ImmunoTargets and Therapy, 2025
Genetic and Plasma Proteomic Approaches to Identify Therapeutic Targets for Graves’ Disease and Graves’ Ophthalmopathy

Ke C., Yu Y., Li J. et al.

Journal for ImmunoTherapy of Cancer, 2025
Oncolytic virus OH2 extends survival in patients with PD-1 pretreated melanoma: phase Ia/Ib trial results and biomarker insights

Wang X., Tian H., Chi Z. et al.

eBioMedicine, 2025
Cardio-metabolic-related plasma proteins reveal biological links between cardiovascular diseases and fragility fractures: a cohort and Mendelian randomisation investigation

Michaëlsson K., Zheng R., Baron J. et al.

Nature Cardiovascular Research, 2025
Large-scale multi-omics identifies drug targets for heart failure with reduced and preserved ejection fraction

Rasooly D., Giambartolomei C., Peloso G. et al.

Nature, 2025
A neoantigen vaccine generates antitumour immunity in renal cell carcinoma

Braun D., Moranzoni G., Chea V. et al.

Journal of Proteome Research, 2025
Serum Immune-Response Protein Biomarkers Based on Olink Technology for Diagnosis of Ischemic Stroke

Wang H., Zhao T., Zeng J. et al.

Journal of Ethnopharmacology, 2025
Lianhua Qingke Tablet in severe pneumonia: Clinical efficacy and immunoregulatory mechanisms

Jin P., Qi H., Zhao J. et al.

Journal of Translational Medicine, 2025
Multi-omics dissection of metabolic dysregulation associated with immune recovery in people living with HIV-1

Wan L., Lam S., Huang H. et al.

Clinical Cancer Research, 2025
Corticosteroid-Dependent Association between Prognostic Peripheral Blood Cell-Free DNA Levels and Neutrophil-Mediated NETosis in Patients with Glioblastoma

Till J., Seewald N., Yazdani Z. et al.

Molecular Neurobiology, 2025
Prospective Investigation Unravels Plasma Proteomic Links to Dementia

Li J., Li J., Chen S. et al.

Rheumatology, 2025
Plasma proteomics for risk prediction and identification of novel drug targets in systemic lupus erythematosus

Yang S., Zhang Y., Ye Z. et al.

Nature Medicine, 2025
Plasma proteomic evidence for increased β-amyloid pathology after SARS-CoV-2 infection

Duff E., Zetterberg H., Heslegrave A. et al.

Nature Communications, 2025
Increased plasma DOPA decarboxylase levels in Lewy body disorders are driven by dopaminergic treatment

Bolsewig K., Willemse E., Sánchez-Juan P. et al.

Heliyon, 2025
Identification of blood plasma protein ratios for distinguishing Alzheimer's disease from healthy controls using machine learning

Safi A., Giunti E., Melikechi O. et al.

Atherosclerosis, 2025
Identifying novel drug targets for calcific aortic valve disease through Mendelian randomization

Xu D., Lu J., Yang Y. et al.

Journal for ImmunoTherapy of Cancer, 2025
Transient lymphocyte count decrease correlates with oncolytic adenovirus efficacy in humans: mechanistic and biomarker findings from TUNIMO phase I trial

Pakola S., Clubb J., Kudling T. et al.

Scientific Reports, 2025
Interconnections between BDH1-plasma protein-type 2 diabetes Mellitus: a mediated mendelian randomization analysis using plasma proteomics

Liu Y., Zhang Y., Wan Q.

The FASEB Journal, 2025
Novel inflammatory markers in intracerebral hemorrhage: Results from Olink proteomics analysis

Hu Z., Chen S., Zhang E. et al.

Nature Genetics, 2025
Integrative proteogenomic analysis identifies COL6A3-derived endotrophin as a mediator of the effect of obesity on coronary artery disease

Yoshiji S., Lu T., Butler-Laporte G. et al.

Pediatric Research, 2025
Distinct pro-inflammatory/pro-angiogenetic signatures distinguish children with Long COVID from controls

Buonsenso D., Cotugno N., Amodio D. et al.